加入收藏 欢迎光临Abbkine Scientific Co., Ltd官方网站全国服务热线:400-6800-830
登录 注册
中文

亚科因(Abbkine)—服务于细胞和蛋白研究全球用户

货号 产品名称 文献标题 IF 杂志名称
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Modulatory Effect of Rosmarinic Acid on H2O2-Induced Adaptive Glycolytic Response in Dermal Fibroblasts 6 Molecules
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Based on network pharmacology, gastrodin attenuates hypertension-induced vascular smooth muscle cell proliferation and PI3K/AKT pathway activation 4 Scientific Reports
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Fabrication of bFGF/polydopamine-loaded PEEK implants for improving soft tissue integration by upregulating Wnt/β-catenin signaling 4 Heliyon
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Activating Transcription Factor 4-mediated Mitochondrial Unfolded Protein Response Alleviates Hippocampal Neuronal Damage in an In Vitro Model of Epileptiform … 4 Neurochemical Research
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Programmable DNA Hydrogel Provides Suitable Microenvironment for Enhancing TSPCS Therapy in Healing of Tendinopathy 3 Small
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Leptinin Yara İyileşmesi Üzerine In Vitro Etkisinin Büyüme Faktörleri Üzerinden İncelenmesi Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi•dergipark
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-β1/Smad2/3 signaling pathway based on network pharmacology … 6 Frontiers in Pharmacology
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Gastrodin attenuates renal injury and collagen deposition via suppression of the TGF-β1/Smad2/3 signaling pathway based on network pharmacology … 6 Frontiers in Pharmacology
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Inhibiting redox-mediated endothelial migration by gadofullerenes for inducing tumor vascular normalization and improving chemotherapy 19 Science Bulletin
BMU106 SuperKine™ 超敏型细胞增殖检测试剂(CCK-8) Effect of Fibroblast Growth Factor 10 and an Interacting Non-Coding RNA on Secondary Hair Follicle Dermal Papilla Cells in Cashmere Goats' Follicle …
意见反馈
在线咨询
扫码关注

微信公众号

返回顶部